Unraveling the Link between Periodontitis and Inflammatory Bowel Disease: Challenges and Outlook
暂无分享,去创建一个
Xuesong He | J. Raufman | Ling-shiang Chuang | S. Mehandru | C. Sears | M. Costalonga | R. Cross | J. Colombel | JebaMercy Gnanasekaran | V. Thumbigere-Math | M. Aimetti | H. Tanwar | G. Baima | Devon Allison | Judy H. Cho | R. Cross | D. Allison
[1] K. Ozato,et al. Mouse Homolog of Human IRF8G388S Mutation Provides Novel Insight into Osteoclastogenesis and Tooth Root Resorption , 2023, bioRxiv.
[2] H. Tettelin,et al. Periodontal disease is associated with increased gut colonization of pathogenic Haemophilus parainfluenzae in patients with Crohn’s disease , 2023, Cell reports.
[3] Zhengmei Lin,et al. Exploration of the shared gene signatures and molecular mechanisms between periodontitis and inflammatory bowel disease: evidence from transcriptome data , 2022, Gastroenterology report.
[4] Xueyang Zhang,et al. Periodontitis-induced oral microbiome alterations provide clues on how periodontitis exacerbates colitis. , 2022, Journal of Clinical Periodontology.
[5] Shuo Zhang,et al. The impact of aging on intestinal mucosal immune function and clinical applications , 2022, Frontiers in Immunology.
[6] A. Gustafsson,et al. Colitis induced by dextran sulphate sodium causes histopathological and immunological changes in the periodontal tissues of Wistar rats. , 2022, Journal of periodontal research.
[7] F. Romano,et al. Periodontitis Prevalence and Severity in Inflammatory Bowel Disease: A Case-Control Study. , 2022, Journal of periodontology.
[8] Xiaoyue Zhang,et al. Fusobacterium nucleatum aggravates ulcerative colitis through promoting gut microbiota dysbiosis and dysmetabolism. , 2022, Journal of periodontology.
[9] N. Pandis,et al. Periodontitis prevalence in patients with ulcerative colitis and Crohn's disease ‐ PPCC: A case–control study , 2022, Journal of clinical periodontology.
[10] G. Heo,et al. Inflammatory bowel disease and periodontitis: A retrospective chart analysis , 2022, Clinical and experimental dental research.
[11] Yan Xu,et al. The oral microbiome analysis reveals the similarities and differences between periodontitis and Crohn's disease-associated periodontitis. , 2022, FEMS Microbiology Letters.
[12] M. Toruner,et al. Evaluation of periodontal status and cytokine levels in saliva and gingival crevicular fluid of patients with inflammatory bowel diseases , 2022, Journal of periodontology.
[13] V. Murthy,et al. Oral Health for All - Realizing the Promise of Science. , 2022, The New England journal of medicine.
[14] E. Kenigsberg,et al. Ulcerative colitis is characterized by a plasmablast-skewed humoral response associated with disease activity , 2022, Nature Medicine.
[15] Chi-Jung Huang,et al. The Periodontopathic Pathogen, Porphyromonas gingivalis, Involves a Gut Inflammatory Response and Exacerbates Inflammatory Bowel Disease , 2022, Pathogens.
[16] Yijun Sun,et al. Porphyromonas gingivalis indirectly elicits intestinal inflammation by altering the gut microbiota and disrupting epithelial barrier function through IL9-producing CD4+ T cells. , 2021, Molecular oral microbiology.
[17] A. Surdacka,et al. Changes in Salivary Parameters of Oral Immunity after Biologic Therapy for Inflammatory Bowel Disease. , 2021, Life.
[18] Yong Zhang,et al. Exosomes derived from 3D-cultured MSCs improve therapeutic effects in periodontitis and experimental colitis and restore the Th17 cell/Treg balance in inflamed periodontium , 2021, International journal of oral science.
[19] Y. Huang,et al. Periodontitis Salivary Microbiota Worsens Colitis , 2021, Journal of dental research.
[20] Kyle J. Gaulton,et al. A single-cell atlas of chromatin accessibility in the human genome , 2021, Cell.
[21] W. Giannobile,et al. A potential pathogenic association between periodontal disease and Crohn’s disease , 2021, JCI insight.
[22] Vineet K. Sharma,et al. Western and non-western gut microbiomes reveal new roles of Prevotella in carbohydrate metabolism and mouth–gut axis , 2021, npj Biofilms and Microbiomes.
[23] F. Romano,et al. Periodontitis and Accelerated Biological Aging: A Geroscience Approach , 2021, Journal of dental research.
[24] Ze Lu,et al. Porphyromonas gingivalis exacerbates ulcerative colitis via Porphyromonas gingivalis peptidylarginine deiminase , 2021, International journal of oral science.
[25] M. Curtis,et al. The role of oral bacteria in inflammatory bowel disease , 2021, Nature Reviews Gastroenterology & Hepatology.
[26] Jacob M. Allen,et al. Psychological stress disrupts intestinal epithelial cell function and mucosal integrity through microbe and host-directed processes , 2021, bioRxiv.
[27] H. Tilg,et al. Calprotectin: from biomarker to biological function , 2021, Gut.
[28] C. Reilly,et al. Calprotectin (S100A8/A9) Is an Innate Immune Effector in Experimental Periodontitis , 2021, Infection and immunity.
[29] J. Colombel,et al. Aging and IBD: A New Challenge for Clinicians and Researchers. , 2021, Inflammatory bowel diseases.
[30] G. Zeng,et al. Porphyromonas gingivalis Promotes Colorectal Carcinoma by Activating the Hematopoietic NLRP3 Inflammasome , 2021, Cancer Research.
[31] Ajay S. Gulati,et al. The “Gum–Gut” Axis in Inflammatory Bowel Diseases: A Hypothesis-Driven Review of Associations and Advances , 2021, Frontiers in Immunology.
[32] N. Buduneli,et al. Shared microbiological and immunological patterns in periodontitis and IBD: A scoping review , 2021, Oral diseases.
[33] K. Katakura,et al. Ingestion of Porphyromonas gingivalis exacerbates colitis via intestinal epithelial barrier disruption in mice. , 2021, Journal of periodontal research.
[34] G. Hajishengallis,et al. Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities , 2021, Nature Reviews Immunology.
[35] M. Somerman,et al. Multiple Idiopathic Cervical Root Resorption: A Challenge for a Transdisciplinary Medical-Dental Team , 2021, Frontiers in Dental Medicine.
[36] H. Fan,et al. IRF/Type I IFN signaling serves as a valuable therapeutic target in the pathogenesis of inflammatory bowel disease. , 2021, International immunopharmacology.
[37] C. M. Figueredo,et al. Higher salivary expression of S100A12 in patients with ulcerative colitis and chronic periodontitis. , 2021, European journal of gastroenterology & hepatology.
[38] A. Lorenzo-Pouso,et al. Association between periodontal disease and inflammatory bowel disease: a systematic review and meta-analysis , 2020, Acta odontologica Scandinavica.
[39] Zhenhua Luo,et al. Porphyromonas gingivalis and Lactobacillus rhamnosus GG regulate the Th17/Treg balance in colitis via TLR4 and TLR2 , 2020, Clinical & translational immunology.
[40] D. Manuel,et al. Life expectancy and health-adjusted life expectancy in people with inflammatory bowel disease , 2020, Canadian Medical Association Journal.
[41] M. Somerman,et al. Integrating Oral and Systemic Health: Innovations in Transdisciplinary Science, Health Care and Policy , 2020, Frontiers in Dental Medicine.
[42] O. Mandelboim,et al. Colon Cancer-Associated Fusobacterium nucleatum May Originate From the Oral Cavity and Reach Colon Tumors via the Circulatory System , 2020, Frontiers in Cellular and Infection Microbiology.
[43] W. Shi,et al. Acquisition and Adaptation of Ultra-small Parasitic Reduced Genome Bacteria to Mammalian Hosts , 2020, Cell reports.
[44] W. Giannobile,et al. The Intermucosal Connection between the Mouth and Gut in Commensal Pathobiont-Driven Colitis , 2020, Cell.
[45] P. Diaz,et al. The role of the microbiota in periodontal disease. , 2020, Periodontology 2000.
[46] M. Nazir,et al. Global Prevalence of Periodontal Disease and Lack of Its Surveillance , 2020, TheScientificWorldJournal.
[47] T. Schmidt,et al. The Bacterial Connection between the Oral Cavity and the Gut Diseases , 2020, Journal of dental research.
[48] H. Xiong,et al. Fusobacterium nucleatum exacerbates colitis by damaging epithelial barriers and inducing aberrant inflammation , 2020, Journal of digestive diseases.
[49] S. Mazzacane,et al. Defining the oral microbiome by whole-genome sequencing and resistome analysis: the complexity of the healthy picture , 2020, BMC Microbiology.
[50] I. Chapple,et al. Treatment of stage I–III periodontitis—The EFP S3 level clinical practice guideline , 2020, Journal of clinical periodontology.
[51] M. Nagasaki,et al. Genetic Analysis of Ulcerative Colitis in Japanese Individuals Using Population-specific SNP Array. , 2020, Inflammatory bowel diseases.
[52] Xiang Gao,et al. Increased risks of dental caries and periodontal disease in Chinese patients with inflammatory bowel disease. , 2020, International dental journal.
[53] R. Genco,et al. The Periodontal Microenvironment: a Potential Reservoir for Intestinal Pathobionts in Crohn’s Disease , 2020, Current Oral Health Reports.
[54] E. Quigley,et al. The microbiome and inflammatory bowel disease. , 2020, The Journal of allergy and clinical immunology.
[55] D. Zawieja,et al. DSS-induced colitis produces inflammation-induced bone loss while irisin treatment mitigates the inflammatory state in both gut and bone , 2019, Scientific Reports.
[56] T. H. Nguyen,et al. The global, regional, and national burden of inflammatory bowel disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017 , 2019, The lancet. Gastroenterology & hepatology.
[57] F. Bucchieri,et al. Probiotics Can Cure Oral Aphthous-Like Ulcers in Inflammatory Bowel Disease Patients: A Review of the Literature and a Working Hypothesis , 2019, International journal of molecular sciences.
[58] M. Parkes,et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults , 2019, Gut.
[59] F. Carinci,et al. Prevalence of Oral Lesions and Correlation with Intestinal Symptoms of Inflammatory Bowel Disease: A Systematic Review , 2019, Diagnostics.
[60] J. Raes,et al. Quantitative microbiome profiling disentangles inflammation- and bile duct obstruction-associated microbiota alterations across PSC/IBD diagnoses , 2019, Nature Microbiology.
[61] Liping Liang,et al. Fusobacterium nucleatum Aggravates the Progression of Colitis by Regulating M1 Macrophage Polarization via AKT2 Pathway , 2019, Front. Immunol..
[62] K. Ozato,et al. Inactivating Mutation in IRF8 Promotes Osteoclast Transcriptional Programs and Increases Susceptibility to Tooth Root Resorption , 2019, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[63] Xinxiang Li,et al. Integrated microbiome and metabolome analysis reveals a novel interplay between commensal bacteria and metabolites in colorectal cancer , 2019, Theranostics.
[64] M. Neurath,et al. Immune cell trafficking and retention in inflammatory bowel disease: mechanistic insights and therapeutic advances , 2019, Gut.
[65] Kevin S. Bonham,et al. Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases , 2019, Nature.
[66] Y. Jeen,et al. Genetic Studies of Inflammatory Bowel Disease-Focusing on Asian Patients , 2019, Cells.
[67] S. Seyedian,et al. A review of the diagnosis, prevention, and treatment methods of inflammatory bowel disease , 2019, Journal of medicine and life.
[68] G. Rossi‐Fedele,et al. Interaction of biologic therapy with apical periodontitis and periodontitis: a systematic review. , 2019, Australian dental journal.
[69] W. Shi,et al. Saccharibacteria (TM7) in the Human Oral Microbiome , 2019, Journal of dental research.
[70] P. de Vos,et al. Age-associated Impairment of the Mucus Barrier Function is Associated with Profound Changes in Microbiota and Immunity , 2019, Scientific Reports.
[71] D. Ojcius,et al. Association between periodontal pathogens and systemic disease , 2019, Biomedical journal.
[72] Sammed N. Mandape,et al. Identification of Specific Oral and Gut Pathogens in Full Thickness Colon of Colitis Patients: Implications for Colon Motility , 2019, Front. Microbiol..
[73] W. Harmsen,et al. Incidence of inflammatory bowel disease by race and ethnicity in a population-based inception cohort from 1970 through 2010 , 2019, Therapeutic advances in gastroenterology.
[74] Chen-feng Qi,et al. T follicular helper cells restricted by IRF8 contribute to T cell-mediated inflammation. , 2019, Journal of autoimmunity.
[75] Luis Pedro Coelho,et al. Extensive transmission of microbes along the gastrointestinal tract , 2018, bioRxiv.
[76] P. Buckhaults,et al. Myeloid-Derived Suppressor Cells Produce IL-10 to Elicit DNMT3b-Dependent IRF8 Silencing to Promote Colitis-Associated Colon Tumorigenesis , 2018, Cell reports.
[77] J. Maul,et al. The Pathogenesis of Extraintestinal Manifestations: Implications for IBD Research, Diagnosis, and Therapy , 2018, Journal of Crohn's & colitis.
[78] P. Usai,et al. Healing of Apical Periodontitis in Patients with Inflammatory Bowel Diseases and under Anti–tumor Necrosis Factor Alpha Therapy , 2018, Journal of endodontics.
[79] R. Lamont,et al. The oral microbiota: dynamic communities and host interactions , 2018, Nature Reviews Microbiology.
[80] P. Dorrestein,et al. Identification of the Bacterial Biosynthetic Gene Clusters of the Oral Microbiome Illuminates the Unexplored Social Language of Bacteria during Health and Disease , 2018, mBio.
[81] C. Huttenhower,et al. Compositional and Temporal Changes in the Gut Microbiome of Pediatric Ulcerative Colitis Patients Are Linked to Disease Course. , 2018, Cell host & microbe.
[82] L. Ding,et al. Porphyromonas gingivalis inhibits M2 activation of macrophages by suppressing &agr;‐ketoglutarate production in mice , 2018, Molecular oral microbiology.
[83] C. Bai,et al. Increased risk of periodontitis among patients with Crohn’s disease: a population-based matched-cohort study , 2018, International Journal of Colorectal Disease.
[84] A. Nakajima,et al. Patients with colorectal cancer have identical strains of Fusobacterium nucleatum in their colorectal cancer and oral cavity , 2018, Gut.
[85] F. Dewhirst,et al. New Insights into Human Nostril Microbiome from the Expanded Human Oral Microbiome Database (eHOMD): a Resource for the Microbiome of the Human Aerodigestive Tract , 2018, mSystems.
[86] R. Haak,et al. Active matrix metalloproteinase‐8 and periodontal bacteria—interlink between periodontitis and inflammatory bowel disease? , 2018, Journal of periodontology.
[87] Z. Xun,et al. Dysbiosis and Ecotypes of the Salivary Microbiome Associated With Inflammatory Bowel Diseases and the Assistance in Diagnosis of Diseases Using Oral Bacterial Profiles , 2018, Front. Microbiol..
[88] W. Turpin,et al. Determinants of IBD Heritability: Genes, Bugs, and More. , 2018, Inflammatory bowel diseases.
[89] C. Elson,et al. Adaptive immune education by gut microbiota antigens , 2018, Immunology.
[90] Feng Chen,et al. Oral microbiomes: more and more importance in oral cavity and whole body , 2018, Protein & Cell.
[91] Yu-Chao Chang,et al. Inflammatory bowel disease as a risk factor for periodontitis under Taiwanese National Health Insurance Research database , 2018, Journal of dental sciences.
[92] H. Takayanagi,et al. Host defense against oral microbiota by bone-damaging T cells , 2018, Nature Communications.
[93] S. Bueno,et al. Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn’s Disease and Ulcerative Colitis , 2018, Front. Immunol..
[94] Nima Hamidi,et al. Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies , 2017, The Lancet.
[95] M. Neurath,et al. Current and emerging therapeutic targets for IBD , 2017, Nature Reviews Gastroenterology & Hepatology.
[96] J. Torres,et al. Familial and ethnic risk in inflammatory bowel disease , 2017, Annals of gastroenterology.
[97] J. Segre,et al. Ectopic colonization of oral bacteria in the intestine drives TH1 cell induction and inflammation , 2017, Science.
[98] F. Shanahan,et al. The oral microbiota in colorectal cancer is distinctive and predictive , 2017, Gut.
[99] G. Rogler,et al. Extraintestinal Manifestations of Pediatric Inflammatory Bowel Disease: Prevalence, Presentation, and Anti-TNF Treatment , 2017, Journal of pediatric gastroenterology and nutrition.
[100] Rongling Wu,et al. Genetic association and epistatic interaction of the interleukin-10 signaling pathway in pediatric inflammatory bowel disease , 2017, World journal of gastroenterology.
[101] T. Buford. (Dis)Trust your gut: the gut microbiome in age-related inflammation, health, and disease , 2017, Microbiome.
[102] Dale Lee,et al. Oral manifestations as the first presenting sign of Crohn’s disease in a pediatric patient , 2017, Journal of clinical and experimental dentistry.
[103] A. Gustafsson,et al. Activity of inflammatory bowel disease influences the expression of cytokines in gingival tissue , 2017, Cytokine.
[104] Hailiang Huang,et al. Fine-mapping inflammatory bowel disease loci to single variant resolution , 2017, Nature.
[105] Stefan Wirtz,et al. Chemically induced mouse models of acute and chronic intestinal inflammation , 2017, Nature Protocols.
[106] C. Langner,et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: Definitions, Diagnosis, Extra-intestinal Manifestations, Pregnancy, Cancer Surveillance, Surgery, and Ileo-anal Pouch Disorders. , 2017, Journal of Crohn's & colitis.
[107] J. Potempa,et al. Manipulation of Neutrophils by Porphyromonas gingivalis in the Development of Periodontitis , 2017, Front. Cell. Infect. Microbiol..
[108] N. Juge,et al. Introduction to the human gut microbiota , 2017, The Biochemical journal.
[109] K. Takeda,et al. Roles of intestinal epithelial cells in the maintenance of gut homeostasis , 2017, Experimental &Molecular Medicine.
[110] I. Thiele,et al. Gut microbiota functions: metabolism of nutrients and other food components , 2017, European Journal of Nutrition.
[111] C. Buskens,et al. 3rd European Evidence-based Consensus on the Diagnosis and Management of Crohn's Disease 2016: Part 2: Surgical Management and Special Situations. , 2017, Journal of Crohn's & colitis.
[112] Harry Sokol,et al. A microbial signature for Crohn's disease , 2017, Gut.
[113] G. Bouma,et al. Gastrointestinal diseases and their oro-dental manifestations: Part 1: Crohn's disease , 2016, BDJ.
[114] C. Oury,et al. The Dual Role of Neutrophils in Inflammatory Bowel Diseases , 2016, Journal of clinical medicine.
[115] B. Chassaing,et al. When pathogenic bacteria meet the intestinal microbiota , 2016, Philosophical Transactions of the Royal Society B: Biological Sciences.
[116] P. Eke,et al. Periodontitis prevalence in adults ≥ 65 years of age, in the USA. , 2016, Periodontology 2000.
[117] C. M. Figueredo,et al. Periodontal and inflammatory bowel diseases: Is there evidence of complex pathogenic interactions? , 2016, World journal of gastroenterology.
[118] Gunnar C. Hansson,et al. Immunological aspects of intestinal mucus and mucins , 2016, Nature Reviews Immunology.
[119] M. Muhvić-Urek,et al. Oral pathology in inflammatory bowel disease. , 2016, World journal of gastroenterology.
[120] D. McGovern,et al. Genetic variation in IBD: progress, clues to pathogenesis and possible clinical utility , 2016, Expert review of clinical immunology.
[121] David C. Wilson,et al. Genome-wide association study implicates immune activation of multiple integrin genes in inflammatory bowel disease , 2016, Nature Genetics.
[122] Weidong Tian,et al. Explaining the disease phenotype of intergenic SNP through predicted long range regulation , 2016, Nucleic acids research.
[123] K. Kirkwood,et al. Aggregatibacter actinomycetemcomitans, a potent immunoregulator of the periodontal host defense system and alveolar bone homeostasis. , 2016, Molecular oral microbiology.
[124] C. M. Figueredo,et al. Cytokine expression in gingival and intestinal tissues of patients with periodontitis and inflammatory bowel disease: An exploratory study. , 2016, Archives of oral biology.
[125] H. Nielsen,et al. Optimized cultivation of Campylobacter concisus from gut mucosal biopsies in inflammatory bowel disease , 2016, Gut Pathogens.
[126] Morris A. Swertz,et al. Population-based metagenomics analysis reveals markers for gut microbiome composition and diversity , 2016, Science.
[127] F. Ryan,et al. Tumour-associated and non-tumour-associated microbiota in colorectal cancer , 2016, Gut.
[128] H. Tilg,et al. The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease. , 2016, Journal of Crohn's & colitis.
[129] W. Leonard,et al. Cutting Edge: Expression of IRF8 in Gastric Epithelial Cells Confers Protective Innate Immunity against Helicobacter pylori Infection , 2016, The Journal of Immunology.
[130] A. Margolles,et al. Intestinal Short Chain Fatty Acids and their Link with Diet and Human Health , 2016, Front. Microbiol..
[131] J. Limdi,et al. Elderly patients and inflammatory bowel disease. , 2016, World journal of gastrointestinal pharmacology and therapeutics.
[132] D. Aronoff,et al. The influence of non-steroidal anti-inflammatory drugs on the gut microbiome. , 2016, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[133] R. Milo,et al. Revised Estimates for the Number of Human and Bacteria Cells in the Body , 2016, bioRxiv.
[134] Jingyuan Fu,et al. Proton pump inhibitors affect the gut microbiome , 2015, Gut.
[135] A. Kühl,et al. Diversity of Intestinal Macrophages in Inflammatory Bowel Diseases , 2015, Front. Immunol..
[136] G. Kaplan,et al. The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.
[137] F. Bushman,et al. Alterations of the Subgingival Microbiota in Pediatric Crohn's Disease Studied Longitudinally in Discovery and Validation Cohorts , 2015, Inflammatory bowel diseases.
[138] C. Romano,et al. Inflammatory Bowel Disease: Genetics, Epigenetics, and Pathogenesis , 2015, Front. Immunol..
[139] R. D'Incà,et al. Intestinal Permeability in Inflammatory Bowel Disease: Pathogenesis, Clinical Evaluation, and Therapy of Leaky Gut , 2015, Mediators of inflammation.
[140] Nora C. Toussaint,et al. Proton Pump Inhibitors Alter Specific Taxa in the Human Gastrointestinal Microbiome: A Crossover Trial. , 2015, Gastroenterology.
[141] John D Lambris,et al. Neutrophil homeostasis and inflammation: novel paradigms from studying periodontitis , 2015, Journal of leukocyte biology.
[142] A. Zellos,et al. Dental Caries and Periodontal Disease in Children and Adolescents with Inflammatory Bowel Disease: A Case–Control Study , 2015, Inflammatory bowel diseases.
[143] M. Fain,et al. Inflammatory bowel disease and the elderly: a review. , 2015, Journal of Crohn's & colitis.
[144] P. Eke,et al. Update on Prevalence of Periodontitis in Adults in the United States: NHANES 2009 to 2012. , 2015, Journal of periodontology.
[145] R. Baldassano,et al. Diet in the pathogenesis and treatment of inflammatory bowel diseases. , 2015, Gastroenterology.
[146] N. Akseer,et al. Oral microbiome composition changes in mouse models of colitis , 2015, Journal of gastroenterology and hepatology.
[147] R. Lamont,et al. Polymicrobial synergy and dysbiosis in inflammatory disease. , 2015, Trends in molecular medicine.
[148] W. Strober,et al. Experimental Models of Inflammatory Bowel Diseases , 2015, Cellular and molecular gastroenterology and hepatology.
[149] G. Hajishengallis,et al. Periodontitis: from microbial immune subversion to systemic inflammation , 2014, Nature Reviews Immunology.
[150] S. Yooseph,et al. Cultivation of a human-associated TM7 phylotype reveals a reduced genome and epibiotic parasitic lifestyle , 2014, Proceedings of the National Academy of Sciences.
[151] P. Vernia,et al. Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients. , 2014, World journal of gastroenterology.
[152] K. Kinzler,et al. Microbiota organization is a distinct feature of proximal colorectal cancers , 2014, Proceedings of the National Academy of Sciences.
[153] F. Turroni,et al. Intestinal Dysbiosis Associated with Systemic Lupus Erythematosus , 2014, mBio.
[154] A. Arsenijević,et al. Potential Dual Immunomodulatory Role of VEGF in Ulcerative Colitis and Colorectal Carcinoma , 2014, International journal of medical sciences.
[155] Sjoerd Post,et al. The mucus and mucins of the goblet cells and enterocytes provide the first defense line of the gastrointestinal tract and interact with the immune system , 2014, Immunological reviews.
[156] H. Al‐Salami,et al. Inflammatory bowel disease: clinical aspects and treatments , 2014, Journal of inflammation research.
[157] J. Round,et al. Defining dysbiosis and its influence on host immunity and disease , 2014, Cellular microbiology.
[158] D. Motooka,et al. Oral pathobiont induces systemic inflammation and metabolic changes associated with alteration of gut microbiota , 2014, Scientific Reports.
[159] Xiaofei Xu,et al. Chemerin aggravates DSS-induced colitis by suppressing M2 macrophage polarization , 2014, Cellular and Molecular Immunology.
[160] S. Mitra,et al. Oxidative stress: an essential factor in the pathogenesis of gastrointestinal mucosal diseases. , 2014, Physiological reviews.
[161] Y. Belkaid,et al. Role of the Microbiota in Immunity and Inflammation , 2014, Cell.
[162] S. Holland,et al. Defective Neutrophil Recruitment in Leukocyte Adhesion Deficiency Type I Disease Causes Local IL-17–Driven Inflammatory Bone Loss , 2014, Science Translational Medicine.
[163] Se Jin Song,et al. The treatment-naive microbiome in new-onset Crohn's disease. , 2014, Cell host & microbe.
[164] B. Paster,et al. Differences in bacterial saliva profile between periodontitis patients and a control cohort. , 2014, Journal of clinical periodontology.
[165] B. Chassaing,et al. Dextran Sulfate Sodium (DSS)‐Induced Colitis in Mice , 2014, Current protocols in immunology.
[166] J. Goedert,et al. Human gut microbiome and risk for colorectal cancer. , 2013, Journal of the National Cancer Institute.
[167] K. Lankarani,et al. Oral manifestation in inflammatory bowel disease: a review. , 2013, World journal of gastroenterology.
[168] T. Attin,et al. Periodontitis and Gingivitis in Inflammatory Bowel Disease: A Case–Control Study , 2013, Inflammatory bowel diseases.
[169] G. Petris,et al. European consensus on the histopathology of inflammatory bowel disease. , 2013, Journal of Crohn's & colitis.
[170] M. Icaza-Chávez,et al. [Gut microbiota in health and disease]. , 2013, Revista de Gastroenterología de México.
[171] Dan Knights,et al. Advances in inflammatory bowel disease pathogenesis: linking host genetics and the microbiome , 2013, Gut.
[172] Taeko Dohi,et al. Dysbiosis of Salivary Microbiota in Inflammatory Bowel Disease and Its Association With Oral Immunological Biomarkers , 2013, DNA research : an international journal for rapid publication of reports on genes and genomes.
[173] R. D. De Lisle,et al. The cystic fibrosis intestine. , 2013, Cold Spring Harbor perspectives in medicine.
[174] T. Yucel-Lindberg,et al. Inflammatory mediators in the pathogenesis of periodontitis , 2013, Expert Reviews in Molecular Medicine.
[175] Gabriel Núñez,et al. Control of pathogens and pathobionts by the gut microbiota , 2013, Nature Immunology.
[176] W. Borgnakke,et al. Risk factors for periodontal disease. , 2013, Periodontology 2000.
[177] N. Pedersen,et al. East–West gradient in the incidence of inflammatory bowel disease in Europe: the ECCO-EpiCom inception cohort , 2013, Gut.
[178] H. Shin,et al. Genome-Wide Association Study of Ulcerative Colitis in Koreans Suggests Extensive Overlapping of Genetic Susceptibility With Caucasians , 2013, Inflammatory bowel diseases.
[179] M. Johansson,et al. The gastrointestinal mucus system in health and disease , 2013, Nature Reviews Gastroenterology &Hepatology.
[180] W. Wade,et al. The oral microbiome in health and disease. , 2013, Pharmacological research.
[181] B. Hartmann,et al. Clinical outcome in IL-10- and IL-10 receptor-deficient patients with or without hematopoietic stem cell transplantation. , 2013, The Journal of allergy and clinical immunology.
[182] L. Dauchet,et al. Natural history of elderly-onset inflammatory bowel disease: a population-based cohort study , 2013, Gut.
[183] A. Gustafsson,et al. Subgingival microflora in inflammatory bowel disease patients with untreated periodontitis , 2013, European journal of gastroenterology & hepatology.
[184] D. Swallow,et al. Refinement in localization and identification of gene regions associated with Crohn disease. , 2013, American journal of human genetics.
[185] R. Lamont,et al. Beyond the red complex and into more complexity: the polymicrobial synergy and dysbiosis (PSD) model of periodontal disease etiology. , 2012, Molecular oral microbiology.
[186] S. Wahl,et al. Porphyromonas gingivalis promotes Th17 inducing pathways in chronic periodontitis. , 2012, Journal of autoimmunity.
[187] Casey T. Weaver,et al. Reciprocal interactions of the intestinal microbiota and immune system , 2012, Nature.
[188] V. Tremaroli,et al. Functional interactions between the gut microbiota and host metabolism , 2012, Nature.
[189] G. Hajishengallis,et al. The keystone-pathogen hypothesis , 2012, Nature Reviews Microbiology.
[190] Y. Khader,et al. The association between inflammatory bowel disease and periodontitis among Jordanians: a case-control study. , 2012, Journal of periodontal research.
[191] S. Riordan,et al. Investigation of the Enteric Pathogenic Potential of Oral Campylobacter concisus Strains Isolated from Patients with Inflammatory Bowel Disease , 2012, PloS one.
[192] Yaoyu E. Wang,et al. Alterations in diversity of the oral microbiome in pediatric inflammatory bowel disease , 2012, Inflammatory bowel diseases.
[193] Ashu Sharma,et al. Fusobacterium nucleatum and Tannerella forsythia Induce Synergistic Alveolar Bone Loss in a Mouse Periodontitis Model , 2012, Infection and Immunity.
[194] C. Parkos,et al. The role of neutrophils during intestinal inflammation , 2012, Mucosal Immunology.
[195] Richard A. Moore,et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. , 2012, Genome research.
[196] Hsin-Jung Wu,et al. The role of gut microbiota in immune homeostasis and autoimmunity , 2012, Gut microbes.
[197] D. Swallow,et al. Dissecting the genetics of complex inheritance: linkage disequilibrium mapping provides insight into Crohn disease. , 2011, American journal of human genetics.
[198] Raphael Zidovetzki,et al. A Comprehensive Analysis of Shared Loci between Systemic Lupus Erythematosus (SLE) and Sixteen Autoimmune Diseases Reveals Limited Genetic Overlap , 2011, PLoS genetics.
[199] John D Lambris,et al. Low-abundance biofilm species orchestrates inflammatory periodontal disease through the commensal microbiota and complement. , 2011, Cell host & microbe.
[200] C. Zenobia,et al. The relationship of the oral microbiotia to periodontal health and disease. , 2011, Cell host & microbe.
[201] Tarah Lynch,et al. Invasive potential of gut mucosa‐derived fusobacterium nucleatum positively correlates with IBD status of the host , 2011, Inflammatory bowel diseases.
[202] Qingshan Li,et al. Transcription factor IRF8 directs a silencing programme for TH17 cell differentiation , 2011, Nature communications.
[203] C. Lees,et al. Guidelines for the management of inflammatory bowel disease in adults , 2011, Gut.
[204] A. Gustafsson,et al. Expression of cytokines in the gingival crevicular fluid and serum from patients with inflammatory bowel disease and untreated chronic periodontitis. , 2011, Journal of periodontal research.
[205] Ashu Sharma. Virulence mechanisms of Tannerella forsythia. , 2010, Periodontology 2000.
[206] Susan Kinder-Haake,et al. Fusobacterium nucleatum Outer Membrane Proteins Fap2 and RadD Induce Cell Death in Human Lymphocytes , 2010, Infection and Immunity.
[207] J. Ebersole,et al. A Model for Chronic Mucosal Inflammation in IBD and Periodontitis , 2010, Digestive Diseases and Sciences.
[208] J. Izard,et al. The Human Oral Microbiome , 2010, Journal of bacteriology.
[209] R. Darveau,et al. Periodontitis: a polymicrobial disruption of host homeostasis , 2010, Nature Reviews Microbiology.
[210] Si Ming Man,et al. Campylobacter concisus and other Campylobacter species in children with newly diagnosed Crohn's disease , 2010, Inflammatory bowel diseases.
[211] B. Finlay,et al. Muc2 Protects against Lethal Infectious Colitis by Disassociating Pathogenic and Commensal Bacteria from the Colonic Mucosa , 2010, PLoS pathogens.
[212] F. Lammert,et al. Clinical periodontal and microbiologic parameters in patients with Crohn's disease with consideration of the CARD15 genotype. , 2010, Journal of periodontology.
[213] Kathryn Roeder,et al. Genome-wide association identifies multiple ulcerative colitis susceptibility loci , 2010, Nature Genetics.
[214] A. Kornbluth,et al. Ulcerative Colitis Practice Guidelines in Adults: American College of Gastroenterology, Practice Parameters Committee , 2010, The American Journal of Gastroenterology.
[215] D. Massi,et al. Pyostomatitis Vegetans: Cellular Immune Profile and Expression of IL-6, IL-8 and TNF-α , 2010, Head and neck pathology.
[216] J. Ebersole,et al. A novel murine model for chronic inflammatory alveolar bone loss. , 2010, Journal of periodontal research.
[217] A. Schäffer,et al. Inflammatory bowel disease and mutations affecting the interleukin-10 receptor. , 2009, The New England journal of medicine.
[218] A. Kantarcı,et al. Hyperactivated B cells in human inflammatory bowel disease , 2009, Journal of leukocyte biology.
[219] J Highfield,et al. Diagnosis and classification of periodontal disease. , 2009, Australian dental journal.
[220] Ludwig Kappos,et al. Meta-analysis of genome scans and replication identify CD6, IRF8 and TNFRSF1A as new multiple sclerosis susceptibility loci , 2009, Nature Genetics.
[221] M. Daly,et al. Identifying Relationships among Genomic Disease Regions: Predicting Genes at Pathogenic SNP Associations and Rare Deletions , 2009, PLoS genetics.
[222] S. Mazmanian,et al. The gut microbiota shapes intestinal immune responses during health and disease , 2009, Nature Reviews Immunology.
[223] Kun Tang,et al. Global diversity in the human salivary microbiome. , 2009, Genome research.
[224] R. Kubilius,et al. Lysozyme and microbiota in relation to gingivitis and periodontitis. , 2009, Medical science monitor : international medical journal of experimental and clinical research.
[225] Y. Gabet,et al. Dextran sodium sulfate-induced colitis causes rapid bone loss in mice. , 2008, Bone.
[226] Judy H. Cho,et al. Genome-wide association defines more than 30 distinct susceptibility loci for Crohn's disease , 2008, Nature Genetics.
[227] A. Gustafsson,et al. Prevalence of periodontitis and DMFT index in patients with Crohn's disease and ulcerative colitis. , 2008, Journal of clinical periodontology.
[228] F. Hoentjen,et al. Pathophysiology of Inflammatory Bowel Diseases , 2008 .
[229] P. Lakatos,et al. Smoking in inflammatory bowel diseases: good, bad or ugly? , 2007, World journal of gastroenterology.
[230] Ken Kleinman,et al. The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States. , 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[231] D. Cohen,et al. Gingival involvement in Crohn disease. , 2007, Journal of the American Dental Association.
[232] Vivien Kwok,et al. Commentary: prognosis revisited: a system for assigning periodontal prognosis. , 2007, Journal of periodontology.
[233] G. Seymour,et al. Relationship between periodontal infections and systemic disease. , 2007, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.
[234] R. Xavier,et al. Unravelling the pathogenesis of inflammatory bowel disease , 2007, Nature.
[235] S. Carding,et al. Inflammatory bowel disease: cause and immunobiology , 2007, The Lancet.
[236] P. Mannon,et al. The fundamental basis of inflammatory bowel disease. , 2007, The Journal of clinical investigation.
[237] D. Foell,et al. S100 proteins expressed in phagocytes: a novel group of damage‐associated molecular pattern molecules , 2007, Journal of leukocyte biology.
[238] S. Amar,et al. Periodontal disease and systemic conditions: a bidirectional relationship , 2006, Odontology.
[239] C. Hart,et al. Bacterial killing in gastric juice--effect of pH and pepsin on Escherichia coli and Helicobacter pylori. , 2006, Journal of medical microbiology.
[240] E. Stange,et al. Extraintestinal manifestations and complications in inflammatory bowel diseases. , 2006, World journal of gastroenterology.
[241] M. Cesta. Normal Structure, Function, and Histology of Mucosa-Associated Lymphoid Tissue , 2006, Toxicologic pathology.
[242] C. Cutler,et al. Dendritic Cells at the Oral Mucosal Interface , 2006, Journal of dental research.
[243] R. Sartor. Mechanisms of Disease: pathogenesis of Crohn's disease and ulcerative colitis , 2006, Nature Clinical Practice Gastroenterology &Hepatology.
[244] B. Größner-Schreiber,et al. Prevalence of dental caries and periodontal disease in patients with inflammatory bowel disease: a case-control study. , 2006, Journal of clinical periodontology.
[245] D. Kinane,et al. Environmental and other modifying factors of the periodontal diseases. , 2006, Periodontology 2000.
[246] J. A. Aas,et al. Defining the Normal Bacterial Flora of the Oral Cavity , 2005, Journal of Clinical Microbiology.
[247] D. Kinane,et al. Advances in the pathogenesis of periodontitis. Group B consensus report of the fifth European Workshop in Periodontology. , 2005, Journal of clinical periodontology.
[248] E. Crushell,et al. A prospective study of the oral manifestations of Crohn's disease. , 2005, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[249] E. Purdom,et al. Diversity of the Human Intestinal Microbial Flora , 2005, Science.
[250] S. Holt,et al. Porphyromonas gingivalis, Treponema denticola, and Tannerella forsythia: the "red complex", a prototype polybacterial pathogenic consortium in periodontitis. , 2005, Periodontology 2000.
[251] R. Baldassano,et al. Extraintestinal manifestations of inflammatory bowel disease. , 2005, Minerva gastroenterologica e dietologica.
[252] S. Socransky,et al. Periodontal microbial ecology. , 2005, Periodontology 2000.
[253] Ashu Sharma,et al. Tannerella forsythia-induced Alveolar Bone Loss in Mice Involves Leucine-rich-repeat BspA Protein , 2005, Journal of dental research.
[254] W. Walker,et al. The role of gut-associated lymphoid tissues and mucosal defence , 2005, British Journal of Nutrition.
[255] P. Petersen,et al. Improving the oral health of older people: the approach of the WHO Global Oral Health Programme. , 2005, Community dentistry and oral epidemiology.
[256] K. Bergh,et al. Gastric juice: a barrier against infectious diseases. , 2005, Basic & clinical pharmacology & toxicology.
[257] Hidde L Ploegh,et al. CX3CR1-Mediated Dendritic Cell Access to the Intestinal Lumen and Bacterial Clearance , 2005, Science.
[258] I. Brandslund,et al. Saliva Interleukin-6 in patients with inflammatory bowel disease , 2005, Scandinavian journal of gastroenterology.
[259] S. Travis,et al. Guidelines for the management of inflammatory bowel disease in adults , 2004, Gut.
[260] B. Pulendran,et al. Human dendritic cells respond to Porphyromonas gingivalis LPS by promoting a Th2 effector response in vitro , 2003, European journal of immunology.
[261] M. Kamm,et al. The dendritic cell: its role in intestinal inflammation and relationship with gut bacteria , 2003, Gut.
[262] M. Neurath,et al. Constitutive p40 promoter activation and IL-23 production in the terminal ileum mediated by dendritic cells. , 2003, The Journal of clinical investigation.
[263] Julie S. Jurenka,et al. Inflammatory bowel disease Part 1: ulcerative colitis--pathophysiology and conventional and alternative treatment options. , 2003, Alternative medicine review : a journal of clinical therapeutic.
[264] Robert J. Palmer,et al. Communication among Oral Bacteria , 2002, Microbiology and Molecular Biology Reviews.
[265] H. Ogata,et al. Animal models of inflammatory bowel disease , 2002, Journal of Gastroenterology.
[266] Judy H. Cho,et al. Clinical Aspects and Pathophysiology of Inflammatory Bowel Disease , 2002, Clinical Microbiology Reviews.
[267] F. Dewhirst,et al. Bacterial Diversity in Human Subgingival Plaque , 2001, Journal of bacteriology.
[268] P. Fleming,et al. The oral cavity in Crohn's disease. , 2001, The Journal of pediatrics.
[269] Shoichiro Tsukita,et al. Multifunctional strands in tight junctions , 2001, Nature Reviews Molecular Cell Biology.
[270] F. Shanahan,et al. Inflammatory bowel disease: immunodiagnostics, immunotherapeutics, and ecotherapeutics. , 2001, Gastroenterology.
[271] S. Humphrey,et al. A review of saliva: normal composition, flow, and function. , 2001, The Journal of prosthetic dentistry.
[272] H. Jenkinson,et al. Subgingival colonization by Porphyromonas gingivalis. , 2000, Oral microbiology and immunology.
[273] R. Genco,et al. Interactions between Periodontal Bacteria and Human Oral Epithelial Cells: Fusobacterium nucleatum Adheres to and Invades Epithelial Cells , 2000, Infection and Immunity.
[274] A. Zinsmeister,et al. Ulcerative colitis in Olmsted County, Minnesota, 1940–1993: incidence, prevalence, and survival , 2000, Gut.
[275] S. Pichyangkul,et al. The immune modulation of B-cell responses by Porphyromonas ginginvalis and interleukin-10. , 2000, Journal of periodontology.
[276] L. Kesavalu,et al. Virulence factors of Porphyromonas gingivalis. , 1999, Periodontology 2000.
[277] P. Fives-Taylor,et al. Virulence factors of Actinobacillus actinomycetemcomitans. , 1999, Periodontology 2000.
[278] R. Lamont,et al. Life Below the Gum Line: Pathogenic Mechanisms ofPorphyromonas gingivalis , 1998, Microbiology and Molecular Biology Reviews.
[279] R. Moots,et al. Intestinal permeability and inflammation in patients on NSAIDs , 1998, Gut.
[280] S. Cornain,et al. Decreased CD4+/CD8+ ratio in major type of recurrent aphthous ulcers: comparing major to minor types of ulcers. , 1998, Asian Pacific journal of allergy and immunology.
[281] A. Zinsmeister,et al. Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. , 1998, Gastroenterology.
[282] R. Steinman,et al. Dendritic cells and the control of immunity , 1998, Nature.
[283] J. Terwilliger,et al. Two stage genome–wide search in inflammatory bowel disease provides evidence for susceptibility loci on chromosomes 3, 7 and 12 , 1996, Nature Genetics.
[284] F. T. Veloso,et al. Immune-related systemic manifestations of inflammatory bowel disease. A prospective study of 792 patients. , 1996, Journal of clinical gastroenterology.
[285] B. Henderson,et al. Virulence factors of Actinobacillus actinomycetemcomitans relevant to the pathogenesis of inflammatory periodontal diseases. , 1995, FEMS microbiology reviews.
[286] P. Prior,et al. Ulcerative colitis and Crohn's disease: a comparison of the colorectal cancer risk in extensive colitis. , 1994, Gut.
[287] W. Wood,et al. Pyodermatitis-pyostomatitis vegetans: a specific marker for inflammatory bowel disease. , 1994, Journal of the American Academy of Dermatology.
[288] K. Das,et al. A shared and unique peptide in the human colon, eye, and joint detected by a monoclonal antibody. , 1994, Gastroenterology.
[289] P. Choi,et al. Similarity of colorectal cancer in Crohn's disease and ulcerative colitis: implications for carcinogenesis and prevention. , 1994, Gut.
[290] C. Lindqvist,et al. Gingival and dental status, salivary acidogenic bacteria, and yeast counts of patients with active or inactive Crohn's disease. , 1994, Oral surgery, oral medicine, and oral pathology.
[291] F. Shanahan,et al. Prevalence and severity of periodontal disease in patients with inflammatory bowel disease. , 1991, Journal of clinical periodontology.
[292] G. Hellers,et al. Prevalence of inflammatory bowel disease among relatives of patients with Crohn's disease. , 1991, Scandinavian journal of gastroenterology.
[293] S. Sakamaki,et al. A shared and unique epitope(s) on human colon, skin, and biliary epithelium detected by a monoclonal antibody. , 1990, Gastroenterology.
[294] J. Rotter,et al. Geographic origins of Jewish patients with inflammatory bowel disease. , 1989, Gastroenterology.
[295] P. Reichart,et al. [Oral manifestations of Crohn's disease]. , 1988, Deutsche Zeitschrift fur Mund-, Kiefer- und Gesichts-Chirurgie.
[296] S. Offenbacher,et al. Potential role of microorganisms isolated from periodontal lesions in the pathogenesis of inflammatory bowel disease , 1986, Infection and immunity.
[297] J. Slots,et al. Actinobacillus actinomycetemcomitans in human periodontal disease. Prevalence in patient groups and distribution of biotypes and serotypes within families. , 1983, Journal of periodontology.
[298] S. Sonis,et al. An analysis of peripheral blood and salivary polymorphonuclear leukocyte function, circulating immune complex levels and oral status in patients with inflammatory bowel disease. , 1982, Journal of periodontology.
[299] R. Genco,et al. Actinobacillus actinomycetemcomitans in human periodontal disease: a cross-sectional microbiological investigation. , 1980, Infection and immunity.
[300] W. Bottomley,et al. Oral extension of regional enteritis (Crohn's disease). Report of a case. , 1972, Oral surgery, oral medicine, and oral pathology.
[301] C. Croft,et al. Ulceration of the mouth, pharynx, and larynx in Crohn's disease of the intestine , 1972, The British journal of surgery.
[302] S. Broitman,et al. Gastric acid barrier to ingested microorganisms in man: studies in vivo and in vitro , 1972, Gut.
[303] I. Todd,et al. Crohn's Disease of the Mouth , 1969, Proceedings of the Royal Society of Medicine.
[304] B. Morson,et al. Crohn's Disease (Regional Enteritis) of the Large Intestine and its Distinction from Ulcerative Colitis , 1960, Gut.
[305] E. Pamer,et al. Correction: Interbacterial mechanisms of colonization resistance and the strategies pathogens use to overcome them , 2019, Mucosal Immunology.
[306] Julia L. Drewes,et al. High-resolution bacterial 16S rRNA gene profile meta-analysis and biofilm status reveal common colorectal cancer consortia , 2017, npj Biofilms and Microbiomes.
[307] C. Roques,et al. Role of Fusobacterium nucleatum in Periodontal Health and Disease , 2016 .
[308] C. Fiocchi,et al. Immunopathogenesis of IBD: current state of the art , 2016, Nature Reviews Gastroenterology &Hepatology.
[309] David C. Wilson,et al. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease , 2012, Nature.
[310] J. Gorski,et al. Cross-reactivity of T cells and its role in the immune system. , 2012, Critical reviews in immunology.
[311] S. Iyer,et al. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. , 2012, Critical reviews in immunology.
[312] D. Owczarek,et al. Proinflammatory cytokines in the saliva of patients with active and non-active Crohn's disease. , 2012, Polskie Archiwum Medycyny Wewnetrznej.
[313] Malfertheiner,et al. World Gastroenterology Organization Practice Guidelines for the diagnosis and management of IBD in 2010. , 2010, Inflammatory bowel diseases.
[314] J. Stockman. Differentiating Ulcerative Colitis from Crohn Disease in Children and Young Adults: Report of a Working Group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America , 2009 .
[315] R. Eliakim,et al. Nutritional status and nutritional therapy in inflammatory bowel diseases. , 2009, World journal of gastroenterology.
[316] W. Hop,et al. Chemokine production by buccal epithelium as a distinctive feature of pediatric Crohn??s disease , 2006 .
[317] E. Melzer,et al. Oral signs and symptoms in relation to disease activity and site of involvement in patients with inflammatory bowel disease. , 2003, Oral diseases.
[318] K. Geboes. Histopathology of Crohn ’ s disease and ulcerative colitis , 2003 .
[319] J. Potempa,et al. Porphyromonas gingivalis proteinases as virulence factors in the development of periodontitis. , 1997, Journal of periodontal research.
[320] H. Smart,et al. Crohn's disease in Jewish people--an epidemiological study in south-east Wales. , 1986, Digestion.
[321] J. Zambon. Actinobacillus actinomycetemcomitans in human periodontal disease. , 1985, Journal of clinical periodontology.
[322] W. Ketterl. [Periodontal diseases]. , 1971, Der Zahnarzt; Colloquium med. dent.
[323] G PLACITELLI,et al. [Ulcerative colitis]. , 1958, La Riforma medica.